Rachel Narozniak, MA

A cross-sectional survey assessed health-related quality of life in colorectal cancer survivors (≤50 years).

Kasi et al compared a novel, artificial intelligence (AI)-based cancer clinical trial search tool with ClinicalTrials.gov to determine which afforded a better user experience.

Although the emergence of COVID-19 initially called the continuation of inflammatory bowel disease (IBD) therapy into question, treatment has proceeded — albeit with added considerations.

Data from the phase-3 investigation of avelumab vs chemotherapy as maintenance therapies for the treatment of gastric or gastroesophageal junction cancer were published in the Journal of Clinical Oncology.